Personalised Medicine is already changing the way diseases are diagnosed, drugs are developed and therapies are matched to particular patient subgroups. But just how well matched is the European patent system to meet the challenges posed by this rapidly evolving technology?
Please join the Rouse Life Sciences Team and industry experts, Dominic O'Brien (GE Healthcare) and Damien O'Farrell (GlaxoSmithKline) for a discussion of the key issues facing companies involved in patenting DNA/protein-based inventions. The panel will also include Rouse panellists Jason Rutt (Global Head of Patents) and Mary Smillie (UK Regulatory and Patent Litigator) and will be chaired by Rebecca Baines (Senior UK Patent Litigator).
If you would like to attend this event, please contact Candice Kelly, spaces are limited.
This event is sponsored by The BioIndustry Association.